TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 123 filers reported holding TG THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $157,000 | +220.4% | 14,150 | +61.7% | 0.00% | – |
Q3 2019 | $49,000 | -27.9% | 8,750 | +11.5% | 0.00% | -100.0% |
Q2 2019 | $68,000 | +7.9% | 7,850 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $63,000 | +142.3% | 7,850 | +23.6% | 0.00% | – |
Q4 2018 | $26,000 | -3.7% | 6,350 | +30.5% | 0.00% | – |
Q3 2018 | $27,000 | -52.6% | 4,865 | +11.5% | 0.00% | -100.0% |
Q2 2018 | $57,000 | +5.6% | 4,365 | +15.9% | 0.00% | 0.0% |
Q1 2018 | $54,000 | +42.1% | 3,765 | -18.4% | 0.00% | 0.0% |
Q4 2017 | $38,000 | +245.5% | 4,615 | +404.4% | 0.00% | – |
Q3 2017 | $11,000 | +22.2% | 915 | 0.0% | 0.00% | – |
Q2 2017 | $9,000 | -35.7% | 915 | -24.7% | 0.00% | – |
Q1 2017 | $14,000 | +250.0% | 1,215 | +49.1% | 0.00% | – |
Q4 2016 | $4,000 | -20.0% | 815 | +32.5% | 0.00% | – |
Q3 2016 | $5,000 | +66.7% | 615 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | – | 615 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |